Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$11.3M Buy
75,882
+73,982
+3,894% +$11.8M 0.7% 36
2022
Q2
$268K Buy
1,900
+700
+58% +$134K 0.02% 276
2022
Q1
$255K Buy
1,200
+300
+33% +$64.9K 0.01% 328
2021
Q4
$208K Sell
900
-20
-2% -$4.86K 0.01% 393
2021
Q3
$210K Sell
920
-20
-2% -$5.01K 0.01% 397
2021
Q2
$227K Buy
+940
New +$206K 0.01% 398
2020
Q3
Sell
-2,400
Closed -$288K 367
2020
Q2
$288K Buy
+2,400
New +$274K 0.02% 240
2019
Q4
Sell
-2,730
Closed -$292K 367
2019
Q3
$292K Buy
+2,730
New +$260K 0.02% 254

Other funds holding TGT

R.H. Bluestein & Co's TGT Position: Q3 2022 in Review

R.H. Bluestein & Co increased its Target (TGT) stake by 3,894% in Q3 2022, buying an estimated $11.8M and bringing the position to 75,882 shares worth $11.3M. The position accounts for 0.7% of the portfolio, ranked #36.

R.H. Bluestein & Co first reported a position in TGT in Q3 2019 and has held it in 8 quarters since. 1,934 funds tracked by Wall St. Rank hold TGT as of Q3 2022.

  • R.H. Bluestein & Co held 75,882 shares of Target worth $11.3M as of Q3 2022.
  • R.H. Bluestein & Co bought 73,982 Target shares in Q3 2022, an estimated $11.8M.
  • Target made up 0.7% of R.H. Bluestein & Co's portfolio in Q3 2022, its #36 holding.
  • R.H. Bluestein & Co first reported a position in Target in Q3 2019 and has held it in 8 quarters since.
  • 1,934 funds tracked by Wall St. Rank held Target as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.